New hope for Tough-to-Treat skin cancer: PTX-100 trial launches
NCT ID NCT06854653
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests a new drug called PTX-100 in people with a rare type of skin lymphoma (CTCL) that has come back or not responded to other treatments. About 115 adults will receive the drug through an IV for several cycles. The goal is to see if it can shrink or control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CTCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Bordeaux - Hopital Saint André
NOT_YET_RECRUITINGBordeaux, Bordeaux, 33000, France
Contact Phone: •••-•••-••••
Contact
-
City of Hope Comprehensive Cancer Cente
RECRUITINGDuarte, California, 91010, United States
Contact
Contact Phone: •••-•••-••••
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 022155450, United States
Contact Phone: •••-•••-••••
Contact
-
Epworth Healthcare
RECRUITINGMelbourne, Victoria, 3002, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hopital Lyon Sud
NOT_YET_RECRUITINGLyon, Pierre-Benite, 69310, France
Contact Phone: •••-•••-••••
Contact
-
Hopital Saint Louis
NOT_YET_RECRUITINGParis, Île-de-France Region, 75010, France
Contact Phone: •••-•••-••••
Contact
-
IRCCS Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi
RECRUITINGBologna, Bologna, 40138, Italy
Contact Phone: •••-•••-••••
Contact
-
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)
RECRUITINGMilan, Milano, 20132, Italy
Contact Phone: •••-•••-••••
Contact
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-••••
Contact
-
Rochester Skin Lymphoma Medical Group. PLLC
RECRUITINGRochester, New York, 14642, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universita degli Studi Di Brescia-Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
RECRUITINGBrescia, Brescia, 25123, Italy
Contact Phone: •••-•••-••••
Contact
-
University of California Irvine
RECRUITINGIrvine, California, 92697, United States
Contact Phone: •••-•••-••••
Contact
-
Virginia Commonwealth University Massey Comprehensive Cancer Cente
RECRUITINGRichmond, Virginia, 980037, United States
Contact Phone: •••-•••-••••
Contact
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, 2145, Australia
Contact Phone: •••-•••-••••
Contact
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.